We are live on ! Find out more
Bessemer Group

Bessemer Group Portfolio holdings

AUM $63.6B
1-Year Est. Return 28.76%
This Fund
S&P 500
This Quarter Est. Return
-15.39%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$40.1B
AUM Growth
-$7.56B
Cap. Flow
+$922M
Cap. Flow %
2.3%
Top 10 Hldgs %
27.94%
Holding
2,099
New
248
Increased
567
Reduced
543
Closed
205

Sector Composition

Rank Sector Weight
1 Technology 20.44%
2 Healthcare 13.15%
3 Financials 12.35%
4 Industrials 9.08%
5 Consumer Discretionary 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTV icon
476
Fortive
FTV
$19.5B
$1.66M ﹤0.01%
40,351
+4,008
+11% +$177K
SLB icon
477
SLB Ltd
SLB
$74.2B
$1.62M ﹤0.01%
45,329
-2,685
-6% -$112K
EPD icon
478
Enterprise Products Partners
EPD
$83.6B
$1.61M ﹤0.01%
66,317
+12,400
+23% +$326K
CFG icon
479
Citizens Financial Group
CFG
$30.8B
$1.61M ﹤0.01%
45,199
+1,397
+3% +$55.2K
IPAC icon
480
iShares Core MSCI Pacific ETF
IPAC
$2.61B
$1.61M ﹤0.01%
30,909
+7,302
+31% +$409K
IGSB icon
481
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$1.6M ﹤0.01%
31,664
-1,000
-3% -$50.9K
UFPI icon
482
UFP Industries
UFPI
$5.14B
$1.6M ﹤0.01%
23,420
+11,470
+96% +$864K
WST icon
483
West Pharmaceutical
WST
$23.7B
$1.59M ﹤0.01%
5,271
-478
-8% -$156K
ADSK icon
484
Autodesk
ADSK
$50.1B
$1.59M ﹤0.01%
9,248
+561
+6% +$108K
REGN icon
485
Regeneron Pharmaceuticals
REGN
$72.9B
$1.58M ﹤0.01%
2,677
+41
+2% +$26.7K
ARCC icon
486
Ares Capital
ARCC
$13.7B
$1.58M ﹤0.01%
88,150
VRSK icon
487
Verisk Analytics
VRSK
$27.8B
$1.57M ﹤0.01%
9,094
-623
-6% -$116K
BSV icon
488
Vanguard Short-Term Bond ETF
BSV
$44.7B
$1.56M ﹤0.01%
20,364
+33
+0.2% +$2.54K
VBK icon
489
Vanguard Small-Cap Growth ETF
VBK
$23.2B
$1.56M ﹤0.01%
7,923
-61,632
-89% -$13.4M
MCHP icon
490
Microchip Technology
MCHP
$41.1B
$1.56M ﹤0.01%
26,836
-739
-3% -$48.9K
LNC icon
491
Lincoln National
LNC
$8.19B
$1.56M ﹤0.01%
33,289
-1,026
-3% -$58.5K
FRC
492
DELISTED
First Republic Bank
FRC
$1.55M ﹤0.01%
10,784
-1,704
-14% -$255K
PYPL icon
493
PayPal
PYPL
$50.3B
$1.55M ﹤0.01%
22,228
-759
-3% -$65.8K
VBR icon
494
Vanguard Small-Cap Value ETF
VBR
$37.7B
$1.55M ﹤0.01%
10,331
-296,969
-97% -$48.7M
TRV icon
495
Travelers Companies
TRV
$82.9B
$1.54M ﹤0.01%
9,116
-503
-5% -$87.4K
PFF icon
496
iShares Preferred and Income Securities ETF
PFF
$13.2B
$1.54M ﹤0.01%
46,762
+425
+0.9% +$14.4K
MPWR icon
497
Monolithic Power Systems
MPWR
$63B
$1.53M ﹤0.01%
3,982
-31
-0.8% -$13.1K
KXI icon
498
iShares Global Consumer Staples ETF
KXI
$1.08B
$1.51M ﹤0.01%
26,207
+3,130
+14% +$189K
TECH icon
499
Bio-Techne
TECH
$11.2B
$1.51M ﹤0.01%
17,468
+3,680
+27% +$345K
NVS icon
500
Novartis
NVS
$304B
$1.51M ﹤0.01%
17,837
-261
-1% -$22.9K

Similar funds

Bessemer Group's Q2 2022 Portfolio in Review

As of Q2 2022, Bessemer Group held 2,099 positions worth $40.1B, down 16% from $47.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Bessemer Group's Q2 2022 filing shows 248 new, 567 increased, 543 reduced and 205 closed positions. Its largest new stake was PG&E: 11,450,214 shares worth $114M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $274M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Bessemer Group's largest Q2 2022 buy was PG&E: 11,450,214 shares worth $114M.
  • Bessemer Group added most to State Street Health Care Select Sector SPDR ETF in Q2 2022, an estimated $497M increase.
  • Bessemer Group's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $274M.
  • Bessemer Group fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $168M.
  • Bessemer Group's ten largest holdings make up 28% of its $40.1B portfolio in Q2 2022.
  • Bessemer Group opened 248 new positions and closed 205 in Q2 2022.
  • Bessemer Group's portfolio value fell 16% quarter-over-quarter to $40.1B.

Based on Bessemer Group's 13F filing for Q2 2022, filed 10 Aug 2022.